Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

alteplase

alteplase
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Cathflo Activase POWDER FOR INJECTION, INJECTABLE 2 mg      
Activase POWDER FOR INJECTION, INTRAVENOUS 50 mg, 100 mg      
VIEW MORE Thrombolytic Agents
CLASS
201220
Comments:

TPA for catheter de-clotting 2 mg/2 ml.

alteplase (tpa) and dornase alfa for intrapleural use

 

Acute Ischemic Stroke (AIS) Considerations: Tenecteplase is the preferred fibrinolytic for AIS. [Tentative Go-Live February 1, 2024]

 

Updated: December 2023 (AIS Indication)

Alteplase to Tenecteplawse Update

Last updated: Apr. 1, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved